Stroke Mimics at 30 Years: Where We Have Been, Where We Are Now, and Where We Are Going

H Khawar, S McFarlane, RB Libman - Stroke, 2025 - ahajournals.org
Stroke mimics and chameleons remain a major challenge to the clinician and clinical
investigator. Misdiagnosis of stroke can result in significant harm to our patients, as well as …

The 100 highest-cited original articles in large vessel occlusions: A bibliometric analysis

A Shahbandi, M Holt… - The Neuroradiology …, 2024 - journals.sagepub.com
Background Large vessel occlusions (LVO) are a common etiology of morbidity and
mortality. The current literature lacks a synthesis of the landscape and trends in research …

Serum glial fibrillary acidic protein in acute stroke: feasibility to determine stroke-type, timeline and tissue-impact

JF Paul, C Ducroux, P Correia, A Daigneault… - Frontiers in …, 2024 - frontiersin.org
Background Interest is emerging regarding the role of blood biomarkers in acute stroke. The
aim of this pilot study was to determine the feasibility of biomarker acquisition in suspected …

Detection of GFAP and D‐Dimer in a Point‐of‐Care Test for Large Vessel Occlusion Ischemic Stroke

E Gaude, D Murphy, JVE Gerstl… - Stroke: Vascular and …, 2025 - ahajournals.org
BACKGROUND The blood biomarkers GFAP (glial fibrillary acidic protein) and D‐dimer
have been shown to accurately diagnose large vessel occlusion ischemic stroke. The …

Finding stroke with a blood test

K Sjölin - 2024 - diva-portal.org
In contrast to many other diseases and conditions, there is no established blood-based
biomarker to aid in the diagnosis, prognosis, or outcome prediction of stroke. The …